Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Thyroid neoplasms malignant
ADR ID BADD_A04303
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.03      Thyroid neoplasms malignant
Description Not Available
MedDRA Code 10043749
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01933Ribavirin0.003956%
BADD_D01966Ropinirole--
BADD_D01992Saxagliptin0.000655%
BADD_D02029Sitagliptin0.000186%
BADD_D02058Sorafenib0.004589%
BADD_D02100Sunitinib0.002239%
BADD_D02105Tacrolimus--
BADD_D02165Teriflunomide0.001447%
BADD_D02170Testosterone0.000091%
BADD_D02236Tofacitinib0.001688%
BADD_D02257Trametinib0.000280%
BADD_D02331Valsartan0.000079%
BADD_D02334Vandetanib0.000224%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib0.000362%
BADD_D02434Cinacalcet0.001368%
BADD_D02440Lisdexamfetamine0.000070%
BADD_D02464Fingolimod0.003183%
BADD_D02526Larotrectinib0.000168%
BADD_D02556Ferrous cation0.001255%
The 2th Page    First    Pre   2    Total 2 Pages